Get the app
US › Healthcare

Heart Test Laboratories Inc. Common Stock (HSCS)

US · Healthcare · Medical Devices

$4.84+27.70%
Last close · 2026-09-17

Latest quarter · ended 2026-07-31

Revenue
$2.1M
Revenue YoY
+110426.3%
Net profit
$-3.17B
EPS
$-0.86
EPS estimate
$-0.78
Net margin
-151,064.0%

EPS came in at -0.86 against a street estimate of -0.78 — a miss of 10.3%.

Key statistics

Market cap
$15.8M
Forward P/E
0.0
P/B
67.85
Book value
$0.07
EPS (TTM)
$-3.48
52-week high
$4.35
52-week low
$1.63
50-day MA
$2.67
200-day MA
$2.55
Beta
1.86

Analyst view

Analysts rate Heart Test Laboratories Inc. Common Stock a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $10.00.

Shareholding

Insiders
17.21%
Institutions
3.52%

Largest institutional holders

FundStake
DRW Securities, LLC1.70%
TFB Advisors LLC0.66%
Geode Capital Management, LLC0.64%
Vanguard Capital Management, LLC0.40%
Vanguard Fiduciary Trust Co0.38%
Tradition Wealth Management LLC0.37%
Citadel Advisors Llc0.32%
UBS Group AG0.14%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Heart Test Laboratories Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.